Current location - Health Preservation Learning Network - Slimming men and women - What is the relationship between Kangmei Industry and Kangmei Medicine?
What is the relationship between Kangmei Industry and Kangmei Medicine?
Kangmei Industry is the main body of Kangmei Pharmaceutical controlled by Ma Xingtian, the founder of Kangmei Group, and was once the largest shareholder of Kangmei Pharmaceutical.

Kangmei Pharmaceutical, 1997, was founded by Mr. Ma Xingtian, a private entrepreneur. The company was located in Puning City, Guangdong Province, and was then named "Guangdong Kangmei Pharmaceutical Co., Ltd.". In 2000, the share reform began. It is one of the large private pharmaceutical enterprises integrating the production, supply and marketing of medicines, Chinese herbal pieces, Chinese herbal medicines and medical devices. The company passed the share-trading reform.

As Kangmei Industry is the second largest shareholder and no longer the holding company of Kangmei Pharmaceutical, the bankruptcy of Kangmei Industry will not lead to the change of the actual controller of Kangmei Pharmaceutical. As the ST Kangmei shares held by Kangmei Industrial are basically pledged to the creditors of financial investment institutions such as banks, these shares will be auctioned according to law, and the shareholders holding more than 5% of Kangmei Pharmaceutical have changed.

Kangmei Pharmaceutical Restructuring Plan;

202 1 1 1 26, Jieyang Intermediate People's Court of Guangdong Province ruled to approve the bankruptcy reorganization plan of Kangmei Pharmaceutical Co., Ltd. and terminated the reorganization procedure. At this point, Kangmei Pharmaceutical's restructuring plan will officially enter the implementation stage.

On February 29th, 2002112, the Intermediate People's Court of Jieyang City, Guangdong Province ruled that the bankruptcy reorganization plan of Kangmei Pharmaceutical Co., Ltd. was completed and the reorganization procedure was terminated. After review by Jieyang Intermediate People's Court, all debts of Kangmei Pharmaceutical have been paid off by cash, shares and trust rights. At this point, Kangmei Pharmaceutical's bankruptcy reorganization ended with the reorganization goal as scheduled.